Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024284 |
---|---|
Receipt number | R000027975 |
Scientific Title | A non-inferiority trial about the efficacy, safety, and effect on QOL of weekly-DPP-4 inhibitor omarigliptin by the comparison with once-daily-DPP-4 inhibitor linagliptin in maintenance hemodialysis patients with type 2 diabetes. |
Date of disclosure of the study information | 2016/10/11 |
Last modified on | 2019/03/31 09:48:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/10/04 15:32:13 | ||
2 | Update | 2017/04/05 11:11:27 | Recruitment status |
|
3 | Update | 2018/04/09 13:55:37 | Recruitment status |
|
4 | Update | 2018/08/22 13:54:40 | Co-sponsor Co-sponsor |
|
5 | Update | 2019/03/29 14:53:50 | Date of IRB Last follow-up date |
|
6 | Update | 2019/03/31 08:44:36 | Number of participants that the trial has enrolled |
|
7 | Update | 2019/03/31 09:02:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
8 | Update | 2019/03/31 09:07:26 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2019/03/31 09:12:04 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
10 | Update | 2019/03/31 09:48:45 | Last follow-up date Date of closure to data entry |